Carregant...
Timing and Targeting of Treatment in Left Ventricular Hypertrophy
In most clinical cases, left ventricular hypertrophy (LVH) occurs over time from persistent cardiac stress. At the molecular level, this results in both transient and long-term changes to metabolic, sarcomeric, ion handling, and stress signaling pathways. Although this is initially an adaptive chang...
Guardat en:
| Publicat a: | Methodist Debakey Cardiovasc J |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Methodist Hospital Houston, Texas
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5385802/ https://ncbi.nlm.nih.gov/pubmed/28413576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14797/mdcj-13-1-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|